본문으로 건너뛰기
부속서 II 항목 1504 CMR개정됨 30 7월 2020

Piperazine

Piperazine은(는) EU 시장에 출시되는 화장품에 사용이 금지된 물질로 부속서 II에 등재되어 있습니다.

사용금지 물질— 부속서 II, EU 규정 1223/2009
항목: 1504
CMR

기록 세부 정보

화학명

Piperazine

화학명 / IUPAC 명칭

Piperazine

규제 정보

규정

(EU) 2019/831

이 법령이 설정한 모든 항목 보기

CMR

카테고리CarcinogenicMutagenicReprotoxic
Cat. 2——✓

주요 데이터

부속서
항목 번호
1504

화학적 정체 및 특성

CAS 110-85-0의 PubChem 2D 화학 구조
CAS 110-85-0PubChem CID 4837

Piperazine

Needle-like white or colorless crystals. Shipped as a solid or suspended in a liquid medium. Very corrosive to skin, eyes and mucous membranes. Solid turns dark when exposed to light. Flash point 190 °F. Used as a corrosion inhibitor and as an insecticide. — CAMEO Chemicals

IUPAC 명칭
piperazine
분자식
C4H10N2
분자량
86.14 g/mol
정확한 질량
86.084398327 Da
XLogP3
-1.5
위상 극성 표면적
24.1 Ų
수소 결합 공여체
2
수소 결합 수용체
2
공유결합 단위
1
정의된 입체중심
0

다른 이름

Diethylenediamine1,4-DiazacyclohexaneHexahydropyrazinePiperazinAntirenPiperazidineDiethyleneimineDispermine
보고된 명칭 16개 더 보기
LumbricalPipersolEraverm1,4-PiperazineWurmirazinUvilonPiperazine, anhydrousWorm-A-Ton1,4-DiethylenediaminePyrazine hexahydrideHexahydro-1,4-diazinePyrazine, hexahydro-Piperazine (USP)NSC-4741RTM4PAL0VPiperazine [USP]
외부 데이터베이스 식별자

추가 과학 데이터베이스의 근거

NIH PubChem PUG-View
식별자 정확히 일치4837

Attributed physical-property, hazard, environmental and use annotations.

  • First Aid: EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.; SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment.; INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) shou 출처: CAMEO Chemicals
  • ERG2024, Guide 153 (Piperazine): General First Aid:; · Call 911 or emergency medical service.; · Ensure that medical personnel are aware of the material(s) involved, take precautions to protect themselves and avoid contamination.; · Move victim to fresh air if it can be done safely.; · Administer oxygen if breathing is difficult.; · If victim is not breathing:; -- DO NOT perform mouth-to-mouth resuscitation; the victim may have ingested or inhaled the substance.; -- If equipped and pulse detected, wash face and mouth, then give artificial respiration using a proper respiratory medical device (bag-valve mask, pocket mask equipped with a one-way valve or other device).; -- If no pulse detected or no respiratory medical device available, provide continuous compressions. Conduct a pulse check every two minutes or monitor for any signs of spontaneous respirations.; · Remove and isolate contaminated clothing and shoes.; · For minor skin contact, avoid spreading material on unaffected skin.; · In case of contact with substance, remove immediately by flushing skin or eyes with running water for at least 20 minutes.; · For severe burns, immediate medical attention is required.; · Effects of exposure (inhalation, ingestion, 출처: Emergency Response Guidebook (ERG)
  • Signal: Danger 출처: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • GHS Hazard Statements: H314: Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]; H317: May cause an allergic skin reaction [Warning Sensitization, Skin]; H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory]; H361fd: Suspected of damaging fertility; Suspected of damaging the unborn child [Warning Reproductive toxicity] 출처: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • Precautionary Statement Codes: P203, P233, P260, P261, P264, P271, P272, P280, P284, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P354+P338, P316, P318, P321, P333+P317, P342+P316, P362+P364, P363, P403, P405, and P501 (click each P-code to see the statement) 출처: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • Note: This chemical does not meet GHS hazard criteria for 0.1% (1 of 768) of reports. 출처: European Chemicals Agency (ECHA)
  • Signal: Danger 출처: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H228 (34.6%): Flammable solid [Danger Flammable solids]; H314 (99.9%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]; H317 (99.7%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H318 (39.7%): Causes serious eye damage [Danger Serious eye damage/eye irritation]; H334 (99.7%): May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory]; H361 (77.3%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]; H361fd (23.4%): Suspected of damaging fertility; Suspected of damaging the unborn child [Warning Reproductive toxicity] 출처: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P203, P210, P233, P240, P241, P260, P261, P264, P264+P265, P271, P272, P280, P284, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P354+P338, P316, P317, P318, P321, P333+P317, P342+P316, P362+P364, P363, P370+P378, P403, P405, and P501 (click each P-code to see the statement) 출처: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 768 reports by companies from 32 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 1 of 768 reports by companies.; There are 31 notifications provided by 767 of 768 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 출처: European Chemicals Agency (ECHA)
  • Signal: Danger 출처: NITE-CMC
  • GHS Hazard Statements: H312: Harmful in contact with skin [Warning Acute toxicity, dermal]; H314: Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]; H317: May cause an allergic skin reaction [Warning Sensitization, Skin]; H318: Causes serious eye damage [Danger Serious eye damage/eye irritation]; H332: Harmful if inhaled [Warning Acute toxicity, inhalation]; H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory]; H335: May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]; H361: Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]; H370: Causes damage to organs [Danger Specific target organ toxicity, single exposure]; H372: Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure]; H402: Harmful to aquatic life [Hazardous to the aquatic environment, acute hazard] 출처: NITE-CMC
  • Precautionary Statement Codes: P203, P233, P260, P261, P264, P264+P265, P270, P271, P272, P273, P280, P284, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P354+P338, P308+P316, P316, P317, P318, P319, P321, P333+P317, P342+P316, P362+P364, P363, P403, P403+P233, P405, and P501 (click each P-code to see the statement) 출처: NITE-CMC
  • GHS Hazard Statements: H302: Harmful if swallowed [Warning Acute toxicity, oral]; H312: Harmful in contact with skin [Warning Acute toxicity, dermal]; H314: Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]; H317: May cause an allergic skin reaction [Warning Sensitization, Skin]; H318: Causes serious eye damage [Danger Serious eye damage/eye irritation]; H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory]; H371: May cause damage to organs [Warning Specific target organ toxicity, single exposure]; H372: Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure] 출처: NITE-CMC
  • NFPA Health Rating: 2 - Materials that, under emergency conditions, can cause temporary incapacitation or residual injury. 출처: Hazardous Substances Data Bank (HSDB)
  • NFPA Fire Rating: 2 - Materials that must be moderately heated or exposed to relatively high ambient temperatures before ignition can occur. Materials would not under normal conditions form hazardous atmospheres with air, but under high ambient temperatures or under moderate heating could release vapor in sufficient quantities to produce hazardous atmospheres with air. 출처: Hazardous Substances Data Bank (HSDB)
  • NFPA Instability Rating: 0 - Materials that in themselves are normally stable, even under fire conditions. 출처: Hazardous Substances Data Bank (HSDB)
  • Environmental Bioconcentration: BCF values less than 0.3 to 0.9 and less than 3.9 were measured using orange-red killifish (Oryzias latipes) which were exposed to 1 and 0.1 ppm, respectively, over an 8-week period(1). According to a classification scheme(2), these BCF values suggest the potential for bioconcentration in aquatic organisms is low(SRC). 출처: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 3.6(SRC), determined from a log Kow of -1.50(2) and a regression-derived equation(3), indicates that piperazine is expected to have very high mobility in soil(SRC). Measured pKa values of 9.73 (first nitrogen) and 5.33 (second nitrogen)(4) indicate that piperazine will exist primarily in cation form in the environment and cations generally adsorb more strongly to soils containing organic carbon and clay than their neutral counterparts(5). Volatilization of piperazine from moist soil surfaces is not expected to be an important fate process(SRC) since cations do not volatilize. Piperazine is not expected to volatilize from dry soil surfaces(SRC) based upon a vapor pressure of 0.16 mm Hg(6). Piperazine may biodegrade in soil based on greater than 51% biodegradation measured after 28 days in a artificial river water total organic carbon (TOC) die-away test; however, only 1.4% degradation occurred after 14 days during a MITI screening test(7,8). 출처: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 3.6(SRC), determined from a log Kow of -1.50(2) and a regression-derived equation(3), indicates that piperazine is not expected to adsorb to suspended solids and sediment(SRC). However, measured pKa values of 9.73 (first nitrogen) and 5.33 (second nitrogen)(4) indicate piperazine will exist almost entirely in the cation form at pH values of 5 to 9 and cations adsorb to suspended solids and sediment more strongly than their neutral counterparts(5). Volatilization of piperazine from water surfaces is not expected to be an important fate process since cations do not volatilize. According to a classification scheme(6), a BCF range of less than 0.3-0.9(7) suggests the potential for bioconcentration in aquatic organisms is low(SRC). Piperazine may biodegrade in water based on greater than 51% biodegradation measured after 28 days in a artificial river water total organic carbon (TOC) die-away test; however, only 1.4% degradation occurred after 14 days during a MITI screening test(7,8). 출처: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), piperazine, which has a vapor pressure of 0.16 mm Hg at 20 °C(2), is expected to exist solely as a vapor in the ambient atmosphere. Vapor-phase piperazine is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 2.3 hours(SRC), calculated from its rate constant of 1.7X10-10 cu cm/molecule-sec at 25 °C(SRC) that was derived using a structure estimation method(3). Piperazine does not contain chromophores that absorb at wavelengths >290 nm and therefore is not expected to be susceptible to direct photolysis by sunlight(4). 출처: Hazardous Substances Data Bank (HSDB)

매핑 기준: Existing checksum-valid CAS to unique PubChem CID match. 가져온 시각: 2026-08-31. 출처 기록 열기

과학적 분류와 유해성 주석은 맥락을 제공할 뿐이며, 위에 표시된 시장별 규제 판단을 대체하지 않습니다.

추가 출처 적용 범위 및 일치 상태
출처결과확인됨
NIH PubChem PUG-View정확히 일치2026-08-31

기록된 불일치는 출처를 확인했다는 유용한 근거이며, 해당 물질이 다른 곳에 존재하지 않는다는 주장이 아닙니다.

체크섬이 유효한 CAS 일치를 통해 2026-09-02에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.

이 기록에 직접 일치하는 항목이 제한적이어서, 부속서 II의 인접 항목도 함께 표시합니다.

부속서 II 1503
같은 부속서의 인접 기록

Cyclohexylamine

CAS: 108-91-8
EC: 203-629-0
부속서 II 1505
같은 부속서의 인접 기록

Hydroxylamine

CAS: 7803-49-8
EC: 232-259-2

Piperazine에 대한 부속서 II의 의미

Piperazine은(는) EU 화장품 규정 1223/2009 부속서 II에 따라 사용금지 물질로 등재되어 있으며 의도적으로 첨가해서는 안 됩니다. 제17조는 별도로, 우수화장품제조관리기준(GMP)에 따라 기술적으로 피할 수 없고 제3조의 안전 요건에 부합하는 비의도적 미량에 대해 다룹니다.

처방 개발자는 원료와 원재료를 선별하여 이 물질이 들어 있지 않은지 확인해야 합니다. 공급업체는 요청 시 부재를 확인하는 문서를 제공해야 합니다.

또한 이 페이지에는 식별자, 부속서 논리 또는 명칭 패턴이 겹치는 관련 부속서 기록 12건이 표시됩니다.

규제 준수 체크리스트

  • 이 물질이 모든 원료와 완제품 처방에 없는지 확인하세요.
  • 원료 공급업체에 부재 확인서 또는 CoA를 요청하세요.
  • 선별 결과를 제품정보파일(PIF)에 기록하세요.
  • 이 물질은 CMR로 분류되어 있습니다. 사용 전에 위의 CMR 표를 검토하고 현재 부속서 II/III 상태를 확인하세요.

자주 묻는 질문

예. Piperazine은(는) EU 화장품 규정 1223/2009 부속서 II에 등재되어 있으며 의도적으로 첨가하는 화장품 원료로는 사용이 금지됩니다. 제17조는 제품이 제3조에 따라 안전하게 유지되는 경우에 한해, GMP에 따라 기술적으로 피할 수 없는 비의도적 미량에 대해 좁은 예외를 둡니다.

CAS 110-85-0은(는) Chemical Abstracts Service가 Piperazine에 부여한 고유 숫자 식별자입니다. 화장품 규제 준수 업무에서 CAS 번호는 규제 데이터베이스, 원료 규격 및 안전성 평가 보고서 전반에서 물질을 교차 참조하는 데 사용됩니다. 같은 물질이 다른 조건이나 다른 부속서에 나타나는 경우 여러 EU 부속서 항목이 같은 CAS 번호를 공유할 수 있습니다.

Piperazine은(는) EU CLP 규정에 따라 CMR(발암성, 변이원성 또는 생식독성)로 분류되어 있습니다. EU 화장품 규정 1223/2009 제15조에 따라 구분 1A 또는 1B의 CMR 물질은 특별히 허용되는 경우를 제외하고 화장품에 사용이 금지됩니다. 구분 2의 CMR 물질은 SCCS가 안전하다고 평가한 경우에만 사용할 수 있습니다. 사용 전에 항상 현재 부속서 상태와 적용 가능한 예외를 확인하세요.

이 사이트의 INCI 검사기에 전체 성분 목록(INCI)을 붙여넣어 모든 부속서 II–VI 항목과 대조하세요. 이 도구는 사용제한, 사용금지 또는 알레르겐으로 표시된 기록과 일치하는 원료를 강조 표시합니다. 완제품 처방이나 원료 선언서를 빠르게 선별하는 데 유용합니다.

부속서 II 기록 Piperazine의 출처 주석

이 페이지는 공개된 유럽연합 집행위원회 화장품 자료에서 가져온 Piperazine의 부속서 II 기록 하나를 요약하고, 가능한 경우 연결된 목록 또는 식별자 일치 항목을 추가합니다.

이 기록 페이지를 이용해 Piperazine의 부속서 II 조건을 검토하되, 최종 규제 판단은 현행 공식 부속서 문구 및 원본 파일로 확인하세요.

도구 및 다음 단계

처방 확인

전체 INCI 목록을 붙여넣어 Piperazine 및 기타 표시된 EU 부속서 기록을 한 번에 찾아보세요.

INCI 검사기

항목 비교

Piperazine을(를) 다른 부속서 기록과 나란히 비교하여 제한 사항, 농도 및 부속서 위치의 차이를 검토하세요.

비교

부속서 둘러보기

부속서 II의 모든 기록을 확인하고 이 부속서 내 물질 간의 규제 조건을 비교하세요.

부속서 II 열기